tm logo
VELAVIGO
Live/Registered
REGISTERED

on 12 Dec 2023

Last Applicant/ Owned by

3F, BUILDING 1, NO. 400 FANGCHUN ROAD

SHANGHAI, PILOT FREE TRADE ZONE

CN

Serial Number

90838630 filed on 20th Jul 2021

Registration Number

7238766 registered on 12th Dec 2023

in the Principal Register

Correspondent Address

Kathryn E. Smith

Kathryn E. Smith

600 Vine Street

Suite 2800

Cincinnati, OH 45202

Filing Basis

1. intent to use

Disclaimer

NO DATA

VELAVIGO

Scientific research for medical purposes in the area of cancerous diseases; scientific investigations for medical purposes; quality control for others; surveying; chemical analysis; research in the field of chemistry; chemical research; chemical research services; chemical research and analysis; cosmetic research; biochemical research and analysis; conducting early evaluation in the field of new p Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical screening; genetic testing for medical purposes; medical analysis services for the diagnosis of cancer; medical services for the treatment of skin cancer; performing diagnosis of diseases; pharmaceutical advice; mental health therapy services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; convalescent home services; food nutrition consultation; beauty salon services; animal breeding; plant nursery services; opticians' services; rental of sanitation facilities

Class [042]
Computer & Software Services & Scientific Services


Scientific research for medical purposes in the area of cancerous diseases; scientific investigations for medical purposes; quality control for others; surveying; chemical analysis; research in the field of chemistry; chemical research; chemical research services; chemical research and analysis; cosmetic research; biochemical research and analysis; conducting early evaluation in the field of new pharmaceuticals; drug discovery services; pharmaceutical product evaluation; pharmaceutical research services; research on the subject of pharmaceuticals; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; scientific research in the nature of conducting clinical trials for others; biotechnology research; biological research; biological research and analysis; biomedical research services; medical laboratory services; medical research; medical research services; meteorological information; material testing; industrial design; architectural services; dress designing; computer programming in the medical field; authenticating works of art; graphic arts design; cloud seeding; handwriting analysis; cartography services; rental of meters for the recording of energy consumption; business card design; graphic design of promotional materials

Class [035]
Advertising, Business & Retail Services


Publicity services; marketing services, namely, presentation of goods on communication media, for retail purposes; business management assistance; marketing; personnel recruitment; compilation of information into computer databases; accounting; sponsorship search; rental of vending machines; rental of sales stands; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale store services for medicines; retail and wholesale store services for pharmaceutical preparations; retail and wholesale store services for sanitary preparations; retail and wholesale store services for medical supplies; retail and wholesale store services for veterinary medicines; retail and wholesale store services for veterinary preparations

Class [005]
Pharmaceutical Products


Chemical preparations for medical purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; bulk drugs in the nature of pharmaceutical preparations, namely, for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; diagnostic preparations for medical purposes; biochemical medicines, namely, for use in treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; diagnostic biomarker reagents for medical purposes; medicines for human purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; pharmaceutical preparations used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; chemico-pharmaceutical preparations used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; drugs in the nature of pharmaceutical preparations for medical purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; biological preparations for medical purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, autoimmune diseases, inflammation, cancer, and antivirals; chemical preparations for pharmaceutical purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, autoimmune diseases, inflammation, cancer, and antivirals; radioactive substances for medical purposes; gases for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants; solutions for contact lenses; media for bacteriological cultures; medicated sweets; dietetic foods and beverages adapted for medical use; depuratives for the body; pesticides; sanitary napkins; cotton for medical purposes; dental abrasives; diapers for pets

Mark Details


Serial Number

No 90838630

Mark Type

No Service Mark

Attorney Docket Number

No JING02128

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Dec 2023REGISTERED-PRINCIPAL REGISTER
12th Dec 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
05th Nov 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
24th Jul 2023EXTENSION OF TIME TO OPPOSE RECEIVED
27th Jun 2023PUBLISHED FOR OPPOSITION
27th Jun 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07th Jun 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23rd May 2023LAW OFFICE PUBLICATION REVIEW COMPLETED
15th May 2023APPROVED FOR PUB - PRINCIPAL REGISTER
12th May 2023CORRESPONDENCE RECEIVED IN LAW OFFICE